WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp., (NASDAQ:PSDV)(ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the product candidate ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that its President and Chief Executive Officer, Dr. Paul Ashton, will be speaking at three upcoming conferences during June.
